Sanford Stem Cell Institute

Sanford Stem Cell Institute
Name	Sanford Stem Cell Institute
Established	2013
Founder	T. Denny Sanford
Parent organization	University of California, San Diego
Director	Catriona Jamieson
Location	La Jolla, California, United States
Website	https://stemcell.ucsd.edu/

Sanford Stem Cell Institute. A premier biomedical research center dedicated to advancing stem cell science and translating discoveries into clinical therapies. Founded through a landmark gift from philanthropist T. Denny Sanford, the institute is an integral part of the University of California, San Diego and its affiliated health system. Its mission encompasses fundamental research into stem cell biology, the development of novel regenerative medicines, and the pursuit of cures for cancers, neurological disorders, and other intractable diseases.

History and founding

The institute was formally established in 2013 following a transformative $100 million gift from South Dakota banker and philanthropist T. Denny Sanford. This donation built upon existing strengths in stem cell research at University of California, San Diego and its partnership with Sanford Health. The creation of the institute consolidated various pioneering efforts, including work from the Moores Cancer Center and the Department of Cellular and Molecular Medicine. Its founding director, Catriona Jamieson, was appointed to lead the integration of these programs under a unified strategic vision focused on translational medicine.

Research focus and programs

Core research is organized into multidisciplinary programs targeting specific disease areas. The hematologic malignancies program investigates leukemia stem cells and pre-malignant conditions like myelodysplastic syndromes. The neurodegenerative disease program focuses on conditions such as Alzheimer's disease, amyotrophic lateral sclerosis, and spinal cord injury. A dedicated solid tumor initiative explores stem cell origins in cancers affecting the pancreas, brain, and breast. The institute also runs a flagship clinical trials unit, notably the Sanford Stem Cell Clinical Center, which fast-tracks experimental therapies from the laboratory to patients at UC San Diego Health.

Key facilities and resources

The institute operates state-of-the-art core facilities supporting its research mission. The Shared Stem Cell Core provides advanced technologies for cell culture, flow cytometry, and genomic sequencing. Researchers utilize the Precision Immunotherapy Suite for developing chimeric antigen receptor T-cell therapies. A critical resource is the Living BioBank, which houses a large collection of patient-derived stem cell lines and organoid models. These resources are housed within the Altman Clinical and Translational Research Institute building and other facilities across the University of California, San Diego campus in La Jolla.

Notable achievements and discoveries

Investigators have made several landmark contributions to the field. Research led by Catriona Jamieson identified key molecular pathways, such as inflammatory signaling in JAK2-mutant cells, that drive progression from myeloproliferative neoplasms to acute leukemia. The institute pioneered the first-in-human clinical trial of an antisense oligonucleotide therapy for myelodysplastic syndromes. Scientists have also developed novel humanized mouse models to study cancer metastasis and created blood-brain barrier organoids to screen drugs for neurological disorders. These efforts have been recognized by awards from the National Institutes of Health and the California Institute for Regenerative Medicine.

Leadership and organization

The institute is directed by Catriona Jamieson, a renowned hematologist and professor of medicine at University of California, San Diego. She oversees a leadership team comprising deputy directors for research, clinical translation, and education. Scientific direction is guided by an internal executive committee and an external board of advisors featuring leaders from academia and industry. The institute functions as an organized research unit within University of California, San Diego, fostering collaborations across departments including the School of Medicine, Jacobs School of Engineering, and Skaggs School of Pharmacy and Pharmaceutical Sciences.

Collaborations and partnerships

Strategic alliances are fundamental to its translational model. A cornerstone partnership with Sanford Health enables multi-site clinical trials and population health research. The institute collaborates extensively with the Moores Cancer Center and the Institute for Genomic Medicine. It is a founding member of the California Institute for Regenerative Medicine's Alpha Stem Cell Clinics network. International collaborations include projects with the Wellcome Trust Sanger Institute and the European Molecular Biology Laboratory. Industry partnerships with biotechnology firms like Fate Therapeutics and Ionis Pharmaceuticals accelerate the commercialization of therapeutic discoveries.

Category:Medical research institutes in California Category:University of California, San Diego Category:Stem cell research organizations